The Liquid Biopsy Summit is dedicated to primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cel.
The Liquid Biopsy Summit covers topics such as:
- Clinical integration of liquid biopsy
- Liquid Biopsy: New Opportunities, Technologies, and Challenges in the Field
- Improving the Quality of Circulating Tumor DNA Measurements
- Circulating Tumor Cells: History and Future Perspectives
- Extracellular vesicles (Evs)
- Circulating Tumor Cells in Monitoring Cancer
- CTC Isolation Platforms and Using CTCs for Monitoring Therapy Responses
- New Tools for Liquid Biopsies: Microfluidic Platforms for the Isolation of CTCs, cfDNA and Exosomes
- Liquid Biopsies in Cancer Immunotherapy Clinical Drug Development
- Dissecting Mechanisms of Breast Cancer Metastasis Using Patient Derived Circulating Tumor Cells
- Liquid Biopsies in Oncology and the Current Regulatory Landscape
- Heterogeneity of Cancer-Derived Extracellular Vesicles
- CtDNA Liquid Biopsy Assay
- Validating Liquid Biopsies in Cancer
